Literature DB >> 25398090

Evaluation of antibody response of killed and live vaccines against porcine epidemic diarrhea virus in a field study.

S Paudel1, J E Park, H Jang, B H Hyun, D G Yang, H J Shin.   

Abstract

BACKGROUND: Porcine epidemic diarrhea virus (PEDV) is an infectious, highly contagious virus, and is an etiological agent of acute entero-pathogenic diarrhea in swine.
OBJECTIVES: Evaluation of the antibody response of two types of PEDV vaccines is to be carried out. ANIMALS AND METHODS: Sows were vaccinated with either live or killed commercial PEDV SM98 (GenBank: GU937797.1) vaccines. Four different groups of sows with five sows in each group were used in this study: the unvaccinated negative control group, the killed virus vaccination group with killed virus boosting (K/K), the live virus vaccinated group with live virus boosting (L/L), and the combination group vaccinated with live virus and subsequently boosted with killed vaccine (L/K). Sows were vaccinated intramuscularly twice at four and two weeks prior to farrowing with 2ml/head vaccine dose. Antibody titers in sow and piglet serum one week after farrowing and that in colostrum were compared by enzyme-linked immunosorbent assay (ELISA) and serum neutralization test.
RESULTS: Vaccination with K/K vaccine induced the highest level of IgG and IgA in sow serum, colostrum, and especially in piglet serum, with the lowest levels found in the L/L group. The major neutralizing activity was also found in the K/K group, particularly in colostrum, with piglets bearing higher neutralizing activity compared to sow sera. Among recombinant spike S1, S2, S3, and nucleocapsid N protein of PEDV, S3 protein presented the highest antibody level in the K/K group.
CONCLUSION: Killed PEDV SM98 vaccine induced higher antibody levels. CLINICAL IMPORTANCE: This study clearly confirms that killed vaccine has induced higher antibody levels and may contribute to the design of future research and vaccine programs.

Entities:  

Keywords:  PEDV; pig; porcine; porcine epidemic diarrhea virus; vaccine

Mesh:

Substances:

Year:  2014        PMID: 25398090     DOI: 10.1080/01652176.2014.973999

Source DB:  PubMed          Journal:  Vet Q        ISSN: 0165-2176            Impact factor:   3.320


  19 in total

1.  Construction of a bivalent DNA vaccine co-expressing S genes of transmissible gastroenteritis virus and porcine epidemic diarrhea virus delivered by attenuated Salmonella typhimurium.

Authors:  Yudi Zhang; Xiaohui Zhang; Xiaodan Liao; Xiaobo Huang; Sanjie Cao; Xintian Wen; Yiping Wen; Rui Wu; Wumei Liu
Journal:  Virus Genes       Date:  2016-03-15       Impact factor: 2.332

Review 2.  Virulence factors in porcine coronaviruses and vaccine design.

Authors:  Sonia Zuñiga; Alejandro Pascual-Iglesias; Carlos M Sanchez; Isabel Sola; Luis Enjuanes
Journal:  Virus Res       Date:  2016-07-07       Impact factor: 3.303

3.  Dietary Probiotic Compound Improves Reproductive Performance of Porcine Epidemic Diarrhea Virus-Infected Sows Reared in a Japanese Commercial Swine Farm under Vaccine Control Condition.

Authors:  Takio Inatomi; Masaaki Amatatsu; Gustavo A Romero-Pérez; Ryo Inoue; Takamitsu Tsukahara
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

4.  A flagellin-adjuvanted inactivated porcine epidemic diarrhea virus (PEDV) vaccine provides enhanced immune protection against PEDV challenge in piglets.

Authors:  Xiangwei Xu; Luping Du; Baochao Fan; Bing Sun; Jinzhu Zhou; Rongli Guo; Zhengyu Yu; Danyi Shi; Kongwang He; Bin Li
Journal:  Arch Virol       Date:  2020-04-06       Impact factor: 2.574

5.  Evaluation of the Efficacy of a Recombinant Adenovirus Expressing the Spike Protein of Porcine Epidemic Diarrhea Virus in Pigs.

Authors:  Xinsheng Liu; Donghong Zhao; Peng Zhou; Yongguang Zhang; Yonglu Wang
Journal:  Biomed Res Int       Date:  2019-10-08       Impact factor: 3.411

6.  Recombinant Chimeric Transmissible Gastroenteritis Virus (TGEV) - Porcine Epidemic Diarrhea Virus (PEDV) Virus Provides Protection against Virulent PEDV.

Authors:  Alejandro Pascual-Iglesias; Carlos M Sanchez; Zoltan Penzes; Isabel Sola; Luis Enjuanes; Sonia Zuñiga
Journal:  Viruses       Date:  2019-07-25       Impact factor: 5.048

7.  Development of an indirect ELISA, blocking ELISA, fluorescent microsphere immunoassay and fluorescent focus neutralization assay for serologic evaluation of exposure to North American strains of Porcine Epidemic Diarrhea Virus.

Authors:  Faten Okda; Xiaodong Liu; Aaron Singrey; Travis Clement; Julie Nelson; Jane Christopher-Hennings; Eric A Nelson; Steven Lawson
Journal:  BMC Vet Res       Date:  2015-08-01       Impact factor: 2.741

8.  Cecropin B Represses CYP3A29 Expression through Activation of the TLR2/4-NF-κB/PXR Signaling Pathway.

Authors:  Xiaoqiao Zhou; Xiaowen Li; Xiliang Wang; Xiue Jin; Deshi Shi; Jun Wang; Dingren Bi
Journal:  Sci Rep       Date:  2016-06-14       Impact factor: 4.379

9.  Rapid and efficient production of cecropin A antibacterial peptide in Escherichia coli by fusion with a self-aggregating protein.

Authors:  Meng Wang; Kaiwen Zheng; Jinglian Lin; Minhua Huang; Yi Ma; Shan Li; Xiaochun Luo; Jufang Wang
Journal:  BMC Biotechnol       Date:  2018-10-05       Impact factor: 2.563

Review 10.  Lactogenic immunity and vaccines for porcine epidemic diarrhea virus (PEDV): Historical and current concepts.

Authors:  Stephanie N Langel; Francine Chimelo Paim; Kelly M Lager; Anastasia N Vlasova; Linda J Saif
Journal:  Virus Res       Date:  2016-05-19       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.